Literature DB >> 15917698

Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis.

Eduardo Nagore1, Vicente Oliver, Rafael Botella-Estrada, Salvador Moreno-Picot, Amelia Insa, José M Fortea.   

Abstract

The aim of this study was to determine independent clinical and pathological prognostic factors for overall and disease-free survival in Spanish melanoma patients. Eight hundred and twenty-three patients with localized melanoma and complete clinical and pathological information were evaluated. The age at diagnosis, gender, location, tumour thickness, invasion level, ulceration, histological subtype, inflammatory infiltrate, mitotic rate, vascular invasion, microscopic satellitosis, regression and cell type were all included. Univariate and multivariate Cox regression analyses were performed for overall and disease-free survival. Gender, histological subtype, tumour thickness, invasion level, ulceration, inflammatory infiltrate, microscopic satellitosis, vascular invasion and mitotic rate were related to overall and disease-free survival in univariate analysis. Age and location were only related to disease-free survival. Only tumour thickness, vascular invasion and gender exhibited independent significance for overall survival in multivariate analysis. For disease-free survival, tumour thickness, location, mitotic rate, vascular invasion and microscopic satellitosis were the sole independent factors. It can be concluded that the Breslow thickness remains the most significant prognostic factor for the survival of patients with localized cutaneous melanoma. Our results support the inclusion of microscopic satellitosis and vascular invasion in the current American Joint Committee on Cancer (AJCC) staging system, although further studies evaluating their separate influence are needed. Mitotic rate is confirmed as an objective and independent predictor of disease-free survival for melanoma patients that should be considered in further revisions of the mentioned staging system.

Entities:  

Mesh:

Year:  2005        PMID: 15917698     DOI: 10.1097/00008390-200506000-00005

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  20 in total

1.  Prognosis of patients with melanoma and microsatellitosis undergoing sentinel lymph node biopsy.

Authors:  Edmund K Bartlett; Meera Gupta; Jashodeep Datta; Phyllis A Gimotty; DuPont Guerry; Xiaowei Xu; David E Elder; Brian J Czerniecki; Douglas L Fraker; Giorgos C Karakousis
Journal:  Ann Surg Oncol       Date:  2013-11-21       Impact factor: 5.344

2.  Lymphatic invasion and angiotropism in primary cutaneous melanoma.

Authors:  Andrea P Moy; Lyn M Duncan; Stefan Kraft
Journal:  Lab Invest       Date:  2016-12-19       Impact factor: 5.662

3.  Correlation of cell cycle regulatory proteins (p53 and p16(ink)⁴(a)) and bcl-2 oncoprotein with mitotic index and thickness of primary cutaneous malignant melanoma.

Authors:  Miloš Kostov; Zaklina Mijović; Dragan Mihailović; Snežana Cerović; Miroslav Stojanović; Marija Jelić
Journal:  Bosn J Basic Med Sci       Date:  2010-11       Impact factor: 3.363

4.  Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma.

Authors:  Emily Z Keung; Jeffrey E Gershenwald
Journal:  J Natl Cancer Inst       Date:  2020-09-01       Impact factor: 13.506

5.  Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.

Authors:  Rita G Ladstein; Ingeborg M Bachmann; Oddbjørn Straume; Lars A Akslen
Journal:  BMC Cancer       Date:  2010-04-14       Impact factor: 4.430

Review 6.  Emerging Biomarkers in Cutaneous Melanoma.

Authors:  Anna Eisenstein; Estela Chen Gonzalez; Rekha Raghunathan; Xixi Xu; Muzhou Wu; Emily O McLean; Jean McGee; Byungwoo Ryu; Rhoda M Alani
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

7.  TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome.

Authors:  F Journe; H Id Boufker; L Van Kempen; M-D Galibert; M Wiedig; F Salès; A Theunis; D Nonclercq; A Frau; G Laurent; A Awada; G Ghanem
Journal:  Br J Cancer       Date:  2011-11-01       Impact factor: 7.640

8.  Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma.

Authors:  Sarah J Storr; Sabreena Safuan; Angana Mitra; Faye Elliott; Christopher Walker; Mark J Vasko; Bernard Ho; Martin Cook; Rabab A A Mohammed; Poulam M Patel; Ian O Ellis; Julia A Newton-Bishop; Stewart G Martin
Journal:  Mod Pathol       Date:  2011-11-11       Impact factor: 7.842

9.  Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR).

Authors:  Richard A Scolyer; Meagan J Judge; Alan Evans; David P Frishberg; Victor G Prieto; John F Thompson; Martin J Trotter; Maureen Y Walsh; Noreen M G Walsh; David W Ellis
Journal:  Am J Surg Pathol       Date:  2013-12       Impact factor: 6.394

10.  The clinical significance of tumor-infiltrating lymphocytes and microscopic satellites in acral melanoma in a korean population.

Authors:  Seok-Jong Lee; Hyun Jung Lim; Yoon Hyuk Choi; Yong Hyun Chang; Weon Ju Lee; Do Won Kim; Ghil Suk Yoon
Journal:  Ann Dermatol       Date:  2013-02-14       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.